pediatric chemistry ' 
emergency procedures
The ability to measure intermediary metabolites in blood is becoming increasingly important in many disease states.
Thus in diabetes there are occasions when it is useful to measure ketone bodies, glycerol, and non-esterified fatty acids (NEFA) concurrently with glucose. In parenteral nutrition it is wise to monitor lactate and pyruvate if sorbitol and fructose-containing solutions are to be used safely. The most useful of these metabolites, apart from glucose, are probably lactate, pyruvate, alanine, glycerol, and ketone bodies. There are manual spectrophotometric enzymic assays for all these substances (1) (2) (3) (4) (5) , but they are laborious, insufficiently sensitive, and expensive. Manual fluorometric assays (6) (7) (8) (9) have the required sensitivity but are time-consuming and, owing to operator fatigue, may lack precision when many samples are being run. There are several automated spectrophotometric (10) and fluorometric techniques for use with "first generation"
continuous-flow systems (Technicon AutoAnalyzer I) or later systems that require use of time-delay coils at temperatures ranging from 25 to 37 #{176}C (11) (12) (13) (14) . Here we describe the enzymic fluorometric automated measurement of six intermediary metabolites at room temperature by use of second-generation automated systems (Technicon AutoAnalyzer II) and a single, easily modified manifold with which 80 samples can be run per hour. The six assays may be performed on samples derived from as little as 0.1 ml of blood, the "micro-system," or more usually 1 to 2 ml, the "normal system."
Materials and Methods

Reagents
All enzymes and coenzymes were obtained from the Boehringer Corp. Ltd., Bell Lane, Lewes, Sussex, U.K. The following enzymes were used: glucose-6-phosphate dehydrogenase (EC 1. reagent: Dissolve 37 mg of ATP, 32 mg of NADP, 140 U of glucose-6-phosphate dehydrogenase and 140 U of hexokinase in 10 ml of 0.4 mol/ liter triethanolamine buffer, pH 7.4. This is used for both "normal" and "micro" assays. 
Reagents for the Lactate Method
Enzyme-coenzyme reagent:
Dissolve 20 mg of NAD and 400 U of lactate dehydrogenase in 10 ml of 0.1 mol/liter phosphate buffer, pH 7.4. This is used for both "normal" and "micro" assays. 
Reagents for the Pyruvate Method
Enzyme-coenzyme reagent:
Dissolve 20 mg of NAD and 15, or 45, U of L-alanine dehydrogenase in 10 ml 0.1 mol/liter phosphate buffer pH 7.4, for the "normal" and "micro" assays, respectively.
Reagents for the Glycerol Method
Measurement of glycerol is based on the following reactions: Enzyme-coenzyme reagent: Dissolve 20 mg of NAD, 20 mg of ATP, 20 U of glycerolkinase, and 30 U of glycerol-3-phosphate dehydrogenase in 10 ml of 0.4 mol/liter triethanolamine buffer, pH 7.4, for the "normal" system. The enzyme amounts were increased to 63 U of glycerokinase and 90 U of glycerol-3-phosphate dehydrogenase for the "micro" system. Table 1 shows the range of working standards prepared for the "normal" and "micro" systems. All stock solutions are prepared in de-ionized distilled water with the exception of glucose, which is commercially available dissolved in a solution of benzoic acid. Perchloric acid, 0.5 mol/liter, is used for all dilutions of the stock solutions.
Reagents for the 3-1-lydroxybutyrate Method
Standard Solutions
Instrumentation
The modules used in all the assay systems are standard AutoAnalyzer 
Preparation of Samples
Whole blood for the "normal system" is deproteinized by adding about 1.5 ml of free-flowing venous blood to a preweighed bottle containing 5 ml of ice-cold 0.8 mol/liter perchloric acid. The sample is well mixed and the bottle reweighed, centrifuged, and the acid supernate is removed for analysis. The dilution of blood is calculated from the weight change observed. When only small samples are available, 100 l of whole blood is added with a capillary pipette to 2.0 ml of ice-cold 0.5 mol/liter perchloric acid. The sample is well mixed, centrifuged, and the acid supernate is removed for analysis. The procedure gives a standard 21-fold dilution for each sample.
Quality Control
Venous blood (150 ml) was taken from a normal subject and diluted with 500 ml of cold 0.8 mol/liter perchloric acid. After the sample was well mixed and centrifuged, the acid supernate was separated and analyzed for each of the intermediary metabolites. One-third of the total sample was then further diluted in 0.5 mol/liter perchloric acid to make a suitable control for the "microsystem."
Small amounts of stock stan- 
Results
Range
The usual range of the assays in our laboratory is shown in Table 1 for the "normal"
and "micro" systems. These are designed to cover usual values for blood metabolites (subject fasting) at the lower end of the range and diabetic values at the upper end. When concentrations above the upper standard are found, assays are repeated with use of less-sensitive systems, or samples are further diluted with the appropriate amount of 0.5 mol/liter perchioric acid.
Precision and Recovery
Within-batch precision was determined by analyzing 20 replicates of samples containing low and high concentrations of each metabolite. The replicates were distributed in no particular order among other samples during an analytical run. Between-batch precision was determined by comparison of the results of quality-control samples over a period of three months. Table 2 shows that, except for 3-hydroxybutyrate, the coefficient of variation both between and within batches is less than 5%, and less than 3% for all but the lowest concentrations.
It can be calculated from the results in Table 2 that acceptable precision is found for concentrations of metabolites well below usual fasting values for the "normal" system (usual dilution of blood 1 in 4) and equivalent to fasting concentrations if the "micro" system is used.
Analytical recovery was determined by adding a known amount of each of the stock solutions to the acid supernate of five blood samples containing various amounts of the metabolites (Table 3) . Mean recovery ranged from 92 to 98%.
Stability of Samples
Venous blood (1.5 ml) from eight subjects was treated as described above. The acid supernates were analyzed as soon as possible on the same day for all metabolites and then apportioned for storage at room temperature, 4 #{176}C, and -20 #{176}C. Assays were repeated three days and 13 days later. Samples stored at -20 #{176}C were also reanalyzed one year later. The results are shown in Table 4 . The concentrations of glucose, lactate, and alanine did not vary with storage, whether samples were kept at -20 #{176}C, 4 #{176}C, or room temperature.
There was a slight upwards trend for 3-hydroxybutyrate, but this was within the variability of the method. Pyruvate proved the least stable of the metabolites, with a 6 to 8% loss in the first three days and a 52% loss at one year. Interestingly, glycerol showed a steady increase in concentration. There was no change with 13 days storage at -20 #{176}C but a 12% increase, mostly occurring in the first three days, if storage was at room temperature. By one year at -20 #{176}C values had increased by 41%.
Sample Blanks
Initial experiments, particularly when the greatest sensitivity was sought, showed sample fluorescence emission not attributable to enzymic activity or NADH. By omitting the particular enzymes involved, this could further be defined as a blank of fluorescence peaking at 440 nm, with a small secondary peak at 620 nm. The precise source of this "native" fluorescence could not be established, but it was noted that the amount varied between individuals and was greatest in samples from severely ill patients. This "native" fluorescence contributed 10-20% of the total fluorescence due to enzymic activity, except for the glucose and lactate assays, where less amplification is required because of the higher concentration an of substrate and the contribution of native fluorescence is therefore negligible. Samples which had been stored showed an increase in these "blank" values. We have therefore routinely run fluorescence blanks for 3-hydroxybutyrate, glycerol, alanine, and pyruvate in the "normal" and "micro" systems. Suitable additions or subtractions are made for these blanks.
If an exceptionally high blank is found in those assays where blanks are routinely run-e.g., 3-hydroxybutyrate-then it is recommended that blanks be run even for lactate and glucose. In samples stored for a year it is necessary to subtract blank values for lactate as well. All values reported in this paper have been corrected for blank fluorescence as necessary.
Discussion
The continuous-flow instrumental system of analysis first described by Skeggs (15) is now widely used. Like all automated systems, it has the advantage of reducing to a minimum the manual manipulations required for any assay. This leads to better precision and increased throughput of samples. Welsh (16) introduced a fluorometer into the flow system as a detector to monitor changes of fluorescence attributable to altered concentrations of NADH. The increased sensitivity of such a system lends itself to the measurement of small intermediary metabolites present in blood. Reduced NAD has a characteristic native fluorescence, whereas the cdrresponding oxidized form does not exhibt the same property (17) . It is possible, therefore, by use of a suitable fluorometer and specific dehydrogenases, now commercially available, to produce a simple automated system for the measurement of those metabolites that require NAD in the reduced or oxidized form as coenzyrpes. Several other workers have described the use of automated fluorometric procedures for the measurement of intermediary -metabolites (11) (12) (13) (14) . The systems include a heating bath with temperatures ranging from 25 to 37 #{176}C. Two reports state, however, that enzyme protein can coagulate at 30#{176}C (11, 12) . We have not found it necessary to include a heating bath, as the ambient temperature changes occurring during an analytical run have a minimal effect on the analysis as measured by the changes occurring in the drift standards during a run.
Neutralization
of the perchloric acid supernate with alkali, as described by some workers (11, 13, 14) , was also omitted, as this was found to be unnecessary and introduced a further dilution factor for the samples. Instead, the working standards were prepared in 0.5 mol/liter perchloric acid and the sampler wash reservoir was filled with the same strength perchloric acid. This ensures similar pH values for the standards and samples.
These were well within the buffer capacity of the systems used. The precision (CV) for each of the assay systems, except for 3-hydroxybutyrate, was less than 5%, even in the "micro" system. The increased coefficient of variation for 3-hydroxybutyrate was attributed not only to the extremely low concentrations being measured but also to the low specific activity of the dehydrogenase. shown by the automated system. With use of substrate concentrations equivalent to the highest values shown in Table  2 , within-batch coefficients of variation were 1.1% for glucose, 6 .2% for lactate, 7.1% for 3-hydroxybutyrate, and 4.1% for pyruvate. Alanine and glycerol were not tested. The native fluorescence of the samples necessitates a blank run for all metabolites, except for glucose and lactate. Longterm storage of the samples, however, leads to an increase in the blank value, and therefore a blank run for lactate is also required, although it does not make a significant contribution to the glucose results. It has not been possible to determine the origin of the extraneous native fluorescence. Any therapeutic agent such as salicylates that will fluoresce at wavelengths near those we used, will certainly significantly increase the extraneous fluorescence. However, blood samples from normal controls not on drug therapy also show fluorescence, and this increases with storage. The analytical system depends on the changes in fluorescence resulting from alterations in NADH concentrations produced by enzymic action. Any fluorescence that is non-enzymic in origin must therefore be taken into account in order to increase the accuracy of the analysis, particularly when very low concentrations of metabolites are being measured. It is worth noting that none of the other systems reported make allowance for blank fluorescence, a possible source of error with those methods. Glucose, lactate, 3-hydroxybutyrate, and alanine have been found to be stable for up to one year when stored at -20 #{176}C.
Pyruvate, however, is less stable and should be assayed immediately.
If this is not possible, then samples for pyruvate assay should be stored at -20 #{176}C, and then only for a few days. Glycerol provides a different problem in that values increase rather than decline on storage of perchloric acid extracts, probably because of hydrolysis of triglycerides or phospholipids. In a practical sense it means that samples for glycerol assay should be either assayed immediately or stored at -20 #{176}C for at most two weeks.
Enzymes and coenzymes used as reagents contribute significantly to the cost of any analysis. Spectrophotometric end-point analyses require comparatively large amounts of both and are therefore expensive.
With the automated fluorometric system described above, the enzyme and coenzyme costs for glucose and 3-hydroxybutyrate are the same as for manual assays, but for all the other metabolites there is a saving of about 90% in reagent costs.
Two systems of sample collection are described in this paper, so-called "normal" and "micro," requiring about 1.5
and 0.1 ml of blood, respectively.
The latter system is particularly suitable for pediatric and small-animal work. It, however, has the advantage of requring more enzyme in order to maintain the sensitivity of the assay systems, otherwise there is an unacceptable increase in electronic "noise" owing to the greater amplification of the fluorometer signal required. The "micro" system also requires accurate measurement of small volumes of blood, whereas in the normal system the blood can be measured directly from a syringe as the exact dilution will be determined gravimetrically. 
